Sumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 37.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,355 shares of the scientific and technical instruments company's stock after selling 8,753 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Cognex were worth $455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mackenzie Financial Corp grew its position in shares of Cognex by 126.2% during the 1st quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock valued at $137,510,000 after acquiring an additional 2,571,457 shares during the period. T. Rowe Price Investment Management Inc. grew its position in shares of Cognex by 32.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock valued at $181,436,000 after acquiring an additional 1,474,832 shares during the period. SG Americas Securities LLC grew its position in shares of Cognex by 16,472.8% during the 1st quarter. SG Americas Securities LLC now owns 819,028 shares of the scientific and technical instruments company's stock valued at $24,432,000 after acquiring an additional 814,086 shares during the period. ING Groep NV acquired a new stake in shares of Cognex during the 1st quarter valued at about $22,191,000. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Cognex by 34.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company's stock valued at $75,756,000 after acquiring an additional 647,955 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.
Cognex Trading Up 0.1%
CGNX opened at $46.54 on Tuesday. The firm has a market capitalization of $7.81 billion, a PE ratio of 65.55 and a beta of 1.50. The firm's 50-day moving average price is $41.22 and its 200 day moving average price is $33.58. Cognex Corporation has a twelve month low of $22.67 and a twelve month high of $47.18.
Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. The company had revenue of $249.09 million for the quarter, compared to analyst estimates of $246.70 million. Cognex had a net margin of 13.13% and a return on equity of 6.65%. Cognex's revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, analysts predict that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.
Cognex Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex's payout ratio is presently 45.07%.
Analyst Ratings Changes
A number of research firms have recently commented on CGNX. DA Davidson raised their target price on Cognex from $32.00 to $35.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Robert W. Baird boosted their target price on shares of Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research note on Monday, June 16th. Citigroup reissued a "neutral" rating and set a $37.00 target price (up previously from $30.00) on shares of Cognex in a research note on Monday, July 14th. KeyCorp raised shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 target price for the company in a research note on Friday, August 1st. Finally, UBS Group boosted their target price on shares of Cognex from $53.00 to $58.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Cognex currently has an average rating of "Moderate Buy" and an average price target of $43.07.
Check Out Our Latest Report on Cognex
Insiders Place Their Bets
In other Cognex news, EVP Sheila Marie Dipalma sold 2,002 shares of the business's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $45.00, for a total value of $90,090.00. Following the transaction, the executive vice president directly owned 8,582 shares in the company, valued at $386,190. The trade was a 18.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by insiders.
Cognex Company Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.